NCT00988728 Efficacy & Safety of SCH 900435 in Schizophrenia (Study P06079)(WITHDRAWN) Status WITHDRAWN Phase PHASE2
NCT00986531 The Effects AZD8529 on Cognition and Negative Symptoms in Schizophrenics Status COMPLETED Phase PHASE1
NCT00986167 Quetiapine Extended Release (XR) for the Management of Psychotic Aggression or Agitation in Adult Acute Psychiatry Status UNKNOWN Phase PHASE4
NCT00982982 Effects of Delta-9-THC and Iomazenil in Healthy Humans Status COMPLETED Phase EARLY_PHASE1
NCT00982020 Study in Adolescents With Schizophrenia or Bipolar Disorder Status COMPLETED Phase PHASE4
NCT00981526 Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia Status COMPLETED Phase PHASE4
NCT00981123 Non-interventional (NI) Study to Observe Efficacy and Usage of Quetiapine in Acute Episodes of Schizophrenia and as Maintenance Therapy Following Standard Clinical Practice in Croatia Status COMPLETED Phase N/A
NCT00980252 Medication Adherence in Schizophrenia: Development of a CBT-Based Intervention Status COMPLETED Phase NA
NCT00977522 A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia Status TERMINATED Phase PHASE2
NCT00975611 Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin Elevation Status TERMINATED Phase PHASE4
NCT00968851 Safety and Cognitive Function Study of EVP-6124 in Patients With Schizophrenia Status COMPLETED Phase PHASE2
NCT00963924 D-cycloserine Augmentation of Cognitive Remediation in Schizophrenia Status COMPLETED Phase NA
NCT00963846 Huperzine for Cognitive and Functional Impairment in Schizophrenia Status COMPLETED Phase PHASE2
NCT00960375 Smoking Cessation for Veterans With Severe and Persistent Mental Illness Status COMPLETED Phase PHASE2/PHASE3
NCT00957294 Metabolic Syndrome in Patients With First-episode Schizophrenia Status COMPLETED Phase N/A
NCT00954122 Efficacy and Safety of SEROQUEL Extended Release (XR) in Acute Schizophrenia Status COMPLETED Phase PHASE4
NCT00952757 Changes in Hyperprolactinemia Secondary to Antipsychotics After Switching to Quetiapine Status COMPLETED Phase N/A